Induction versus adjuvant chemotherapy combined with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study

医学 内科学 鼻咽癌 肿瘤科 危险系数 放化疗 诱导化疗 比例危险模型 单变量分析 多元分析 化疗 放射治疗 置信区间
作者
Xiaoli Mu,Hongyan Liu,Juan Wu,Shi Chen,Xingchen Peng,Jing Wang,Zhigong Wei,Ling He,Ji-Yan Liu,Zejun Lu,Yonglin Su
出处
期刊:Aging [Impact Journals LLC]
卷期号:14 (16): 6727-6739
标识
DOI:10.18632/aging.204246
摘要

Background: Currently available evidence favors the combination of chemotherapy with concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma (LANPC). However, the optimal timing for additional chemotherapy is unclear. This study was conducted to compare the efficacy and toxicity of induction chemotherapy plus concurrent chemoradiotherapy (IC+CCRT) versus concurrent chemoradiotherapy plus adjuvant chemotherapy (CCRT+AC). Methods: Two medical centers in China enrolled patients with LANPC (stage III-IVB) between January 2009 and May 2020. Through the use of propensity score matching (PSM), baseline characteristics were balanced. The primary endpoint was overall survival (OS), which was evaluated by the Kaplan-Meier method and log-rank test. Potential independent prognostic factors were identified using univariate and multivariate Cox proportional hazard analyses. Based on the chi-squared test, we compared the adverse events associated with treatment between the groups. Results: After the implementation of PSM, 159 patients treated with IC+CCRT and 72 patients treated with CCRT+AC were eventually enrolled in this study. There was no significant difference between patients treated with IC+CCRT and CCRT+AC in terms of 3-year OS (94.7% versus 90.9%, p=0.816), progression-free survival (PFS) (91.2% versus 83.1%, p=0.588), locoregional recurrence-free survival (LRFS) (92.5% versus 81.8%, p=0.478), or distant metastasis-free survival (DMFS) (93.4% versus 88.2%, p=0.783). There was no prognostic significance of the treatment for OS, PFS, LRFS, or DMFS (all p > 0.05) in the univariate and multivariate analyses. Patients treated with CCRT+AC had a higher incidence of grade 3 to 4 leucopenia (p=0.001) and neutropenia (p=0.001) than those treated with IC+CCRT. Conclusions: IC plus CCRT achieved comparable survival outcomes to CCRT plus AC and had a lower incidence of toxicity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
科研小白完成签到,获得积分20
1秒前
1秒前
正直凌文发布了新的文献求助10
2秒前
2秒前
XIXIw发布了新的文献求助10
3秒前
3秒前
3秒前
4秒前
4秒前
慕慕倾发布了新的文献求助10
4秒前
ccjjpp1243发布了新的文献求助10
5秒前
6秒前
poohpooh完成签到,获得积分10
6秒前
6秒前
科研通AI2S应助萌酱采纳,获得10
7秒前
一一一完成签到,获得积分10
7秒前
奇异物质发布了新的文献求助10
7秒前
斯文的青枫完成签到,获得积分10
7秒前
爆米花应助ZHQ采纳,获得10
9秒前
HHHH发布了新的文献求助10
10秒前
12秒前
12秒前
14秒前
知行合一发布了新的文献求助10
14秒前
剩下的盛夏完成签到,获得积分10
15秒前
majiawei完成签到,获得积分10
17秒前
丘比特应助ccjjpp1243采纳,获得10
18秒前
20秒前
20秒前
20秒前
20秒前
无花果应助plant采纳,获得10
21秒前
gwenjing发布了新的文献求助10
21秒前
故酒发布了新的文献求助100
22秒前
22秒前
niulugai完成签到,获得积分10
23秒前
沉默妙竹发布了新的文献求助10
24秒前
量子星尘发布了新的文献求助150
24秒前
25秒前
高分求助中
A Comprehensive Review on the Chemical Composition, Pharmacology and Clinical Applications of Ganoderma 3000
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
T/CIET 1202-2025 可吸收再生氧化纤维素止血材料 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3956172
求助须知:如何正确求助?哪些是违规求助? 3502400
关于积分的说明 11107420
捐赠科研通 3232954
什么是DOI,文献DOI怎么找? 1787093
邀请新用户注册赠送积分活动 870482
科研通“疑难数据库(出版商)”最低求助积分说明 802019